Product Code: GVR-4-68040-281-4
U.S. Apheresis Equipment Market Growth & Trends:
The U.S. apheresis equipment market size is anticipated to reach USD 1.64 billion by 2030, expanding at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Continuous improvements in apheresis technology have led to the development of more efficient, user-friendly, and cost-effective equipment. The rise in the prevalence of chronic diseases in the U.S., such as kidney failure, cancer, and autoimmune disorders, has led to a higher demand for apheresis procedures. For instance, according to the National Library of Medicine, in 2023, approximately 1,958,310 new cancer cases were observed in the U.S., that in turn, drives the need for apheresis equipment.
New product launches in the U.S. market bring innovative features and technological advancements to the equipment, improving their efficiency, accuracy, and performance. Regulatory approvals ensure that the apheresis equipment meets safety and efficacy standards, which is crucial for the end-users, such as hospitals and clinics. For instance, according to the Association for the Advancement of Blood & Biotherapies, in August 2023, Terumo BCT received its FDA clearance for its Reveous Automated Whole Blood Processing System. This boosts consumer confidence and contributes to the growth of the market.
U.S. Apheresis Equipment Market Report Highlights:
- Based on product, disposable apheresis kits dominated the market with more than 70% share in 2023 owing to the feature of eliminating the risk of cross-contamination and infection transmission between patients, as each kit is used only once and then discarded
- The device segment is expected to grow at the fastest CAGR over the forecast period
- Based on application, the neurology segment held the largest market share in 2023. Apheresis helps to remove the disease-causing antibodies or immune cells, thus reducing inflammation and protecting the nerves
- Market players operating in the U.S. apheresis equipment market include Haemonetics Corporation, Fresenius Kabi, B. Braun SE, Mallinckrodt Pharmaceuticals
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Procedure
- 1.2.4. Technology
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product
- 2.2.2. Application
- 2.2.3. Procedure
- 2.2.4. Technology
- 2.3. Competitive Insights
Chapter 3. U.S. Apheresis Equipment Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. U.S. Apheresis Equipment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. U.S. Apheresis Equipment Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. U.S. Apheresis Equipment Market by Product Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. Disposable Apheresis Kits
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Device
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Apheresis Equipment Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. U.S. Apheresis Equipment Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Renal Disease
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Neurology
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Hematology
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Others
- 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Apheresis Equipment Market: Procedure Estimates & Trend Analysis
- 6.1. Procedure Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. U.S. Apheresis Equipment Market by Procedure Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Photopheresis
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 6.4.2. Plasmapheresis
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. LDL Apheresis
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Plateletpheresis
- 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Leukapheresis
- 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Erythrocytapheresis
- 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.7. Others
- 6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Apheresis Equipment Market: Technology Estimates & Trend Analysis
- 7.1. Technology Market Share, 2023 & 2030
- 7.2. Segment Dashboard
- 7.3. U.S. Apheresis Equipment Market by Technology Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 7.4.1. Membrane Filtration
- 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 7.4.2. Centrifugation
- 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. U.S. Apheresis Equipment Market: Region Estimates & Trend Analysis
- 8.1. Regional Market Share, 2023 & 2030
- 8.2. U.S. Apheresis Equipment Market by Region Outlook
- 8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 8.3.1. West
- 8.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 8.3.2. Midwest
- 8.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.3. Northeast
- 8.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.4. Southwest
- 8.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.5. Southeast
- 8.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company heat map analysis, 2023
- 9.4. Company Profiles
- 9.4.1. Haemonetics Corporation
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Fresenius Kabi
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. B. Braun SE
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Mallinckrodt Pharmaceuticals
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. Nikkiso Co., Ltd.
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. Asahi Kasei Medical Co., Ltd.
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. Terumo BCT
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives